Jennifer Hockings, Pharm D, PhD
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Jennifer Hockings, Pharm D, PhD
Jennifer Hockings, PharmD, PhD, is a Pharmacogenomicist Clinical Specialist in Cleveland Clinic’s Genomic Medicine Institute. She sees patients on Main Campus and remotely via telegenetics.
Dr. Hockings is a board-certified Pharmacotherapy Specialist, and is licensed by the Ohio State Board of Pharmacy. She earned her doctor of philosophy degree in cancer biology from the University of Arizona. Upon receiving her doctoral degree, Dr. Hockings served as a professor of biology at the Blue Mountain College in Blue Mountain, Mississippi, before earning her doctor of pharmacy degree from the University of Mississippi.
Her post-graduate training includes a research fellowship at St. Jude’s Children’s Research Hospital, a pharmacy residency at Methodist LeBonheur, and a pharmacogenomics residency at St. Jude’s Children’s Research Hospital.
Dr. Hockings has published numerous peer-reviewed research articles in distinguished journals, including Cancer Research, Breast Cancer Research and Biochimica et Biophysica Acta, and has presented at professional association meetings including the American Society of Health-System Pharmacists and the American Association for Cancer Research.
Education & Professional Highlights
Appointed
2018
Education & Fellowships
Residency - St. Jude Children's Research Hospital
Pahrmacogenetics
Memphis,
TN USA
2017
Residency - Methodist University Hospital
Memphis,
TN USA
2016
Graduate School - University of Mississippi
PharmD
University,
MS USA
2015
Fellowship - St. Jude Children's Research Hospital
Postdoctoral research fellow
Memphis,
TN USA
2008
Graduate School - University of Arizona
Tucson,
AZ USA
2005
Undergraduate - University of Arizona
Tucson,
AZ USA
2001
Certifications
- Board Certified Pharmacotherapy Specialist (BCPS)
Specialty Interests
1. Impact of pharmacagenomics on medication therapy and patient outcomes. 2. Oncology
Research & Publications
See publications for Jennifer Hockings, Pharm D, PhD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 10/4/2023, Dr. Hockings has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
